TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT05563480 · COMPLETED
Trial details
- NCT number
- NCT05563480
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-27
- Primary completion
- 2025-05-28
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.